1. |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Eur Respir J, 2017, 49(3). pii: 1700214.
|
2. |
Guo L, Chughtai AR, Jiang H, et al. Relationship between polycythemia and in-hospital mortality in chronic obstructive pulmonary disease patients with low-risk pulmonary embolism. J Thorac Dis, 2016, 8(11): 3119-3131.
|
3. |
Aleva FE, Voets LWLM, Simons SO, et al. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis. Chest, 2017, 151(3): 544-554.
|
4. |
Squizzato A, Donadini MP, Galli L, et al. Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost, 2012, 10(7): 1276-1290.
|
5. |
Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest, 2005, 115(12): 3355-3362.
|
6. |
Tabuchi A, Kuebler WM. Endothelium-platelet interactions in inflammatory lung disease. Vascul Pharmacol, 2008, 49(4-6): 141-150.
|
7. |
Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest, 2005, 115(12): 3378-3384.
|
8. |
Maclay JD, McAllister DA, Johnston S, et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax, 2011, 66(9): 769-774.
|
9. |
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014, 35(43): 3033-3069.
|
10. |
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J, 2005. 26(2): 319-338.
|
11. |
Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr, 2003, 16(10): 1091-1110.
|
12. |
McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. ; and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009, 53(17): 1573-1619.
|
13. |
Schumann G, Canalias F, Joergensen PJ, et al. IFCC reference procedures for measurement of the catalytic concentrations of enzymes: corrigendum, notes and useful advice. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)--IFCC Scientific Division. Clin Chem Lab Med, 2010, 48(5): 615-621.
|
14. |
Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J, 2003, 22(Suppl 47): 3s-14s.
|
15. |
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr, 1998, 68(4): 899-917.
|
16. |
McDonald TP, Cottrell M, Clift R. Effects of short-term hypoxia on platelet counts of mice. Blood, 1978, 51(1): 165-175.
|
17. |
Wedzicha JA, Cotter FE, Empey DW. Platelet size in patients with chronic airflow obstruction with and without hypoxaemia. Thorax, 1988, 43(1): 61-64.
|
18. |
Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia. Thorax, 1991, 46(7): 504-507.
|
19. |
Kumakura H, Kanai H, Aizaki M, et al. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease. J Vasc Surg, 2010, 52(1): 110-117.
|
20. |
Lainscak M, von Haehling S, Doehner W. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle, 2011, 2(2): 81-86.
|
21. |
Man SFP, Leipsic JA, Man JP, et al. Is atherosclerotic heart disease in COPD a distinct phenotype?. Chest, 2011, 140(3): 569-571.
|
22. |
Shapira-Rootman M, Beckerman M, Soimu U, et al. The prevalence of pulmonary embolism among patients suffering from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol, 2015. 22(3): 257-260.
|
23. |
de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, et al. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis, 2012, 7: 679-686.
|
24. |
Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax, 2011, 66(9): 764-768.
|
25. |
Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA, 2013, 309(22): 2353-2361.
|
26. |
Marchena Yglesias PJ, Nieto Rodríguez JA, Serrano Martínez S, et al. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Interna, 2006, 23(3): 105-110.
|
27. |
Harrison MT, Short P, Williamson PA. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?. Thorax, 2014, 69(7): 609-615.
|
28. |
Collaborative overview of randomised trials of antiplatelet therapy--III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ, 1994, 308(6923): 235-246.
|
29. |
Short PM, Lipworth SI, Elder DH, et al. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ, 2011(342): d2549.
|
30. |
Fruchter O, Yigla M, Kramer MR. Lipid profile and statin use: the paradox of survival after acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci, 2015, 349(4): 338-343.
|